Galaxy Diagnostics and Virginia Tech Unite to Strengthen Direct Detection Approaches for Lyme Disease By Nicole Danielle Bell, CEO of Galaxy Diagnostics and author of What Lurks in the Woods The Diagnostic Uncertainty Clinicians Face Clinicians evaluating patients with suspected tick-borne disease routinely manage diagnostic uncertainty. Prior exposure, immune variability, and timing-dependent antibody responses can… Continue reading Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics
Two LymeX Innovators, One Mission: Advancing Reliable Lyme Diagnostics